News from iOPharma^TM

• 17 Feb 2015 04:39 GMT Doctors on social media slam NICE diabetes guidance
  Doctors are seemingly outraged by new draft guidelines on the treatment of diabetes published by the National Institute for Health and Care Excellence, according to a recent study of conversations among healthcare professionals in social media. Read more at: http://www.pharmatimes.com/Article/15-... More
• 14 Feb 2015 13:32 GMT Pharma is boosting pipelines to avoid patent cliff
  Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors Service. The firm that produces reports around the financial outlook of companies and countries says pharma has improved its pipelines of new drugs, ... More
• 11 Feb 2015 13:32 GMT Uruguay Marijuana Licenses Lure Bidders From Canada to Germany
  (Bloomberg) — Canadian medical-marijuana producer Tilray and the founder of a German cannabis products retailer are among 11 investors bidding for a foothold in a formerly illegal industry in Uruguay: marijuana farms. Once the government issues the licenses, pot could reach pharmacies in th... More
• 26 Jan 2015 05:34 GMT AstraZeneca plc Lowered to “Underweight” at Barclays
  Barclays lowered shares of AstraZeneca plc (LON:AZN) to an underweight rating in a research report released on Friday morning. Barclays has also modified their ratings on a number of other stocks in the few days. The firm lowered its price target on shares of Goldcorp Inc. from $30.00 to $26.00. ... More
• 23 Jan 2015 05:28 GMT Institute of Medicine Maps Out Clinical Trial Data Sharing Program
  Investigators and sponsors of clinical trials will have to make more detailed data available following study completion, according to a new report from an Institute of Medicine expert panel, but they will have several months to disclose individual case reports and complete data supporting registr... More